Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 05/24 09:59:58 pm
397.7 USD   +1.29%
05/18DJAmgen Researchers Discover Gene Associated With Lower Risk of Hea..
05/16 Biotechnology Stocks Show Strong Move To The Upside
05/11DJHealth Insurers Push to Tie Drug Prices to Outcomes--Update
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/11/2013 | 04:44pm CEST
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on REGENERON PHARMACEUTICALS
05/19 REGENERON PHARMACEUTICALS : U.S. Patents Awarded to Inventors in Massachusetts (..
05/19 REGENERON PHARMACEUTICALS : U.S. Patents Awarded to Inventors in New Jersey (May..
05/19 REGENERON PHARMACEUTICALS : Assigned Patent
05/18DJAmgen Researchers Discover Gene Associated With Lower Risk of Heart Disease
05/16 Biotechnology Stocks Show Strong Move To The Upside
05/16 REGENERON PHARMACEUTICALS : Licenses gene-editing technology in nine-figure deal
05/12 REGENERON PHARMACEUTICALS : Announces Positive Topline Results from Phase 2/3 Fa..
05/12 REGENERON PHARMACEUTICALS : Studies from Regeneron Pharmaceuticals Inc. Yield Ne..
05/11DJHealth Insurers Push to Tie Drug Prices to Outcomes--Update
05/11DJHealth Insurers Push to Tie Drug Prices to Outcomes
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials